Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of Repeated Dosing Regimens of AL-794 in Healthy Volunteers

Trial Profile

A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of Repeated Dosing Regimens of AL-794 in Healthy Volunteers

Discontinued
Phase of Trial: Phase I

Latest Information Update: 01 Jun 2018

At a glance

  • Drugs JNJ-5806 (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Alios BioPharma
  • Most Recent Events

    • 25 May 2018 Status changed from recruiting to discontinued as the data received to date did not support continuation of the study.
    • 27 Mar 2018 Status changed from not yet recruiting to recruiting.
    • 28 Feb 2018 Planned initiation date changed from 4 Feb 2018 to 3 Mar 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top